By Ralph Tarantino, PhDPharmaceutical Consultant and Principal, SteriTech Solutions, LLCMiddletown, NJ
The FDA’s most recent response to the anti-cancer drug shortage crisis may be a perfect example of “too little, too late.” What follows will not be a rant about offshore outsourcing or the regulatory climate in general. However, the FDA decision (See FDA’s Press Release regarding shortages of anti-cancer drugs here) to allow Sun Pharma’s version of Doxil (doxorubicin HCl liposome injection) into the United States to replace the approved Ben Venue product may be a dangerous one for patients with ovarian cancer. [More]
By Michael L. Krychman, MDCMMedical Director The Sexual Medicine Center, Executive Director Southern California Center of Sexual Health and Survivorship Medicine Newport Beach, CA, Faculty Member University of Southern California Los Angeles, CA.
As a health care professional I see that many women are now becoming more active in their own sexual satisfaction and discussing issues of sexual health concerns; however, it is remarkably amazing how different the media sees the difference between male and female sexuality. It is not uncommon to pick up a lay magazine or watch a prime time television show and see an advertisement for a male erectile medication. The media has essentially embraced male erectile dysfunction and even use the word erection. But when was the last time we saw an ad about vaginal dryness or female sexual pain or a woman’s loss of sexual interest? [More]
By Barbara Gottlieb, MD, MPHAssociate Professor, Harvard Medical School; Associate Professor, Harvard School of Public Health; Brookside Community Health Center and Associate Physician, Brigham and Women's Hospital, Boston, MA
Although my patients have very diverse backgrounds (ie, in class, age, ethnicity, race, education, language, health literacy), they are quite similar in what they fear and what they don’t fear. For my female patients, breast cancer is at the top of the list. Somewhere beneath that is diabetes, then heart disease, stroke, and others that you would expect. I’m pretty sure that for most of my patients, lung cancer doesn’t even make it on the list. [More]